Zymeworks Inc (ZYME)
9.10
-0.28
(-2.99%)
USD |
NASDAQ |
May 17, 16:00
9.10
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Cash from Investing (Quarterly): -7.316M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.316M |
| December 31, 2023 | -1.337M |
| September 30, 2023 | -7.02M |
| June 30, 2023 | -60.67M |
| March 31, 2023 | -138.22M |
| December 31, 2022 | -22.06M |
| September 30, 2022 | -30.43M |
| June 30, 2022 | -21.93M |
| March 31, 2022 | 20.57M |
| December 31, 2021 | -1.857M |
| September 30, 2021 | 42.37M |
| June 30, 2021 | 27.24M |
| March 31, 2021 | 76.85M |
| December 31, 2020 | 43.40M |
| September 30, 2020 | 37.59M |
| June 30, 2020 | 80.34M |
| March 31, 2020 | -204.77M |
| Date | Value |
|---|---|
| December 31, 2019 | -88.20M |
| September 30, 2019 | -22.77M |
| June 30, 2019 | 63.37M |
| March 31, 2019 | 22.00M |
| December 31, 2018 | -36.01M |
| September 30, 2018 | -13.30M |
| June 30, 2018 | -72.26M |
| March 31, 2018 | 12.54M |
| December 31, 2017 | -15.53M |
| September 30, 2017 | -1.392M |
| June 30, 2017 | -20.56M |
| March 31, 2017 | 6.589M |
| December 31, 2016 | -2.727M |
| September 30, 2016 | -1.633M |
| June 30, 2016 | -21.09M |
| March 31, 2016 | 0.001M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-204.77M
Minimum
Mar 2020
80.34M
Maximum
Jun 2020
-10.74M
Average
-4.438M
Median
Cash from Investing (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -10.80M |
| MariMed Inc | -4.266M |
| Viemed Healthcare Inc | -5.365M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -37.67M |
| Cash from Financing (Quarterly) | 2.123M |
| Free Cash Flow | -77.13M |
| Free Cash Flow Per Share (Quarterly) | -0.5026 |
| Free Cash Flow to Equity (Quarterly) | -38.32M |
| Free Cash Flow to Firm (Quarterly) | -38.32M |
| Free Cash Flow Yield | -11.87% |